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frequency routine surveillance EMB in post-HT patients, even in the early
period when non-invasive diagnostics are not applicable.
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Introduction: Becker muscular dystrophy (BMD) is an X-linked recessive
disorder with dystrophin mutation. Dilated Cardiomyopathy (DCM) is a
leading cause of death in BMD patients. Herein, we are presenting a
patient with BMD that initially sought medical attention for acute onset of
systolic heart failure that highlights the importance of careful clinical
assessment and appropriate work up.
Case Report: A 29-year-old male with medical history of asthma presented to the hospital with progressive dyspnea and leg swelling. He
was diagnosed with DCM with an LVIDD of 6.5 cm and LV ejection fraction of 20-25% by echocardiogram. Coronary angiogram
revealed no coronary artery disease. Initial blood work and electrocardiogram are below (Figure). Cardiac MRI showed severely
reduced biventricular systolic function with near circumferential,
sub-epicardial to mid-myocardial delayed gadolinium enhancement
(Figure). Initial differential diagnosis included prior myocarditis vs.
burnt out sarcoidosis. It was subsequently noted that patient began
recurrently falling with muscle weakness from age 20 years with
chronically elevated AST and CK. His exam was notable for atrophy of the bilateral quadriceps muscles, decreased muscular strength
and bilateral calves hypertrophy. Electromyography showed evidence
of chronic proximal and distal myopathy, predominantly affecting
the lower extremity. Skeletal muscle biopsy showed fascicular atrophy and hypertrophy, focal endomyosial fibrosis and an increase of
central nuclei without evidence of inflammation or granuloma which
was most suggestive of a muscular dystrophy. Genetic testing was
then completed and showed hemizygous dystrophin mutation confirming diagnosis of BMD.
Summary: BMD has a diffuse phenotype and should be considered in
young patients with cardiomyopathy and chronically elevated CK and
AST. A thorough clinical history, exam, and CMR can assist in directing
need for skeletal muscle biopsy and subsequent genetic testing.

Introduction: This topic warrants consideration due to the popularity of
sublingual administration of tacrolimus and the possibility of deleterious
effects. There are significantly different characteristics of sublingual tacrolimus compared to oral administration. In bypassing enterohepatic circulation, a greater proportion of circulating tacrolimus may be available in a
’free’ form, unbound to proteins and blood cells. This is similar to a rapid
intravenous delivery of calcineurin inhibitor which has noted toxicities.
Case Report: (Case 1) A 49 year old male underwent heart transplant without induction, sublingual tacrolimus was started and after two days of
trough levels of 5ng/mL or below, the dose was increased to 4mg SL bid,
levels increased from to 17.8 ng/mL. While creatinine increased from
1.7 mcg/dL (POD#2) to a peak of 5.1 mcg/dL on POD#6. The patient was
otherwise quite stable. Tacrolimus was held temporarily then converted to
oral administration. The creatinine eventually recovered to a value of
1.5mg/dL. The average tacrolimus trough level (while receiving oral dosing) during this period of creatinine recovery was 5.9 ng/ML. (Case 2) 64
year old man with ICM received a heart transplant with uneventful operative course and no induction. He received tacrolimus 1mg orally pre-operatively. Then he received 2mg Of the drug sublingually twice daily until
POD # 2. On POD#3 he experienced a generalized tonic-clonic seizure
that terminated with anticonvulsant therapy. The tacrolimus trough levels
rose quickly after the initial tacrolimus sublingual dosing postoperatively,
measured at 11.4 ng/mL on POD#2. Neurology recommended a switch to
cyclosporine (goal trough level 200-250ng/mL). The patient remained on
levetiracetam for 14 days, no further epileptic activity was observed. Renal
function during this episode from a creatinine of 1.4 mg/dL on POD#1 to
4.2 mg/dL on POD#3.
Summary: The molecular size of tacrolimus allows for passage into the
glomerulus when in the free form. This may also facilitate blood/brain barrier transport. The presented cases provide cause for consideration of possible toxicity of tacrolimus given sublingually, particularly in patients
whose levels rise rapidly. Through rapid absorption, the drug may not
have sufficient time to bind to proteins and cells before it reaches end
organs in which toxicity occurs.
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Introduction: Atrial fibrillation (AF) is highly prevalent after the age of
55 years. However, it can be associated with infiltrative cardiomyopathy.
Case Report: A 63 years old had new onset of palpitation and shortness of
breath. He presented to ED with rapid AF at rate of 140 bpm treated with
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